3.8 C
London

C

C

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial
Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen and MorphoSys declined as the announcement was made. Malignant pleural mesothelioma is a rare cancer that affects more than 25,000 people around the world. Around 15,000 new cases are seen every...

What are the symptoms of mesothelioma?

What are the symptoms of mesothelioma?
The main symptoms of mesolthelioma are: feeling out of breath chest pain coughing The symptoms may take years to manifest themselves and the condition is usually very slow to appear. The speed at which it progresses will depend on the type of mesothelioma. Epithelioid mesothelioma is the slowest to progress and usually responds the best...

LATEST